CHEMOTECH
ChemoTech is a Scandinavian company based at Medicon Village in Lund, Sweden. The company’s founders have extensive experience of cancer treatment through surgical oncology and clinical development. The company is dedicated to using its unique patented know-how to develop innovation in cancer care through genuine research and clinical trials.
CHEMOTECH
Industry:
Health Care Therapeutics
Founded:
2013-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.chemotech.se
Total Employee:
1+
Status:
Active
Contact:
+46 (0)10 218 93 00
Email Addresses:
[email protected]
Total Funding:
327.86 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Font Awesome Wordpress Plugins Mobile Non Scaleable Content IPv6
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
ATAI Life Sciences
ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.
MediGene
MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.
Current Employees Featured
Founder
Stock Details
Investors List
Bengt Engström
Bengt Engström investment in Post-IPO Equity - ChemoTech
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - ChemoTech
Official Site Inspections
http://www.chemotech.se Semrush global rank: 7.85 M Semrush visits lastest month: 428
- Host name: 172.67.145.2
- IP address: 172.67.145.2
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ChemoTech"
About ChemoTech - ChemoTech
ChemoTech, an international life science company based in Lund, Sweden, was founded in 2015 by a team of experts in radiation physics, surgical oncology, and clinical development.See details»
ChemoTech - Crunchbase Company Profile & Funding
ChemoTech is a Scandinavian company based at Medicon Village in Lund, Sweden. The company’s founders have extensive experience of cancer …See details»
Scandinavian ChemoTech AB (STO:CMOTEC.B) Company Profile
Aug 13, 2025 Company profile for Scandinavian ChemoTech AB (publ) (STO:CMOTEC.B) with a description, list of executives, contact details and other key facts.See details»
Scandinavian ChemoTech - Products, Competitors, Financials, …
ChemoTech's shares (CMOTEC B) are listed on Nasdaq First North Growth Market in Stockholm and Redeye AB is the company's Certified Adviser. Read more at: www.chemotech.se . Mar …See details»
ChemoTech Company Profile - Office Locations, Competitors
Oct 29, 2024 ChemoTech has 5 employees across 2 locations and kr2.82 m in annual revenue in FY 2023. See insights on ChemoTech including office locations, competitors, revenue, …See details»
Company Management - ChemoTech
Company Management Extensive expertise ChemoTech has a very competent management and Board of Directors with extensive expertise and substantial experience of medical research …See details»
ChemoTech - DevelopmentAid
About ChemoTech has developed the patented technology platform TSE (Tumour Specific Electroporation) which involves treating superficial tumours with electrical impulses along with …See details»
Scandinavian ChemoTech AB (publ) | LinkedIn
Scandinavian ChemoTech AB (publ) | 817 följare på LinkedIn. ChemoTech is a R&D based company in the field of oncology. The Company is presently marketing and selling it's …See details»
Scandinavian ChemoTech Welcomes Strategic Investors from the …
Jul 29, 2025 Scandinavian ChemoTech AB (publ) ChemoTech is a Swedish medical technology company based in Lund that has developed a patented technology platform to offer cancer …See details»
Investor Relations - ChemoTech
Investors Investor Relations Corporate governance ChemoTech is a Swedish public limited liability company established in Sweden. Its registration date with the Swedish Companies …See details»
Scandinavian ChemoTech Restructures Loans and Doubles the …
Jan 30, 2025 ChemoTech is pleased to announce the signing of new restructured loan agreements to replace its previous short-term bridge financing. The new agreements include a …See details»
Our Technology - ChemoTech
ChemoTech remains committed to advancing TSE through continued R&D efforts, for both curative and later palliative stages of treatments. Our extended target for TSE includes …See details»
English - ChemoTech
Jul 24, 2025 Scandinavian ChemoTech’s Animal Care continues its momentum, achieving an order intake exceeding USD 230,000 (2.3 MSEK) in Q1 2025 which makes it the best quarter …See details»
Market Overview - ChemoTech
Chemotech's market overview provides insights into how their innovative solutions address specific needs across various industries.See details»
ChemoTech
20 Aug 2025 02:50 Regulatory Scandinavian ChemoTech’s Animal Care, a pioneer in veterinary oncology innovation, is proud to announce a significant milestone: more than 2,500 kits for …See details»
ChemoTech: Pioneering the Future of Cancer Treatment with It’s …
Aug 27, 2024 ChemoTech’s flagship product, the IQwaveâ„¢ system, exemplifies this commitment by offering a powerful and effective treatment option for various cancer …See details»
Scandinavian ChemoTech Restructures Loans and Doubles the
Jan 30, 2025 Scandinavian ChemoTech Restructures Loans and Doubles the Duration to 12 Months ChemoTech is pleased to announce the signing of new restructured loan agreements …See details»
Scandinavian ChemoTech delar upp affärsområdena för att stärka ...
Dec 30, 2024 Sedan 2021 har Scandinavian ChemoTech drivit två distinkta affärsområden – Human Care och Animal Care. Även om Human Care var koncernens initiala fokus, har …See details»
MFN.se > Scandinavian ChemoTech > Scandinavian ChemoTech …
Scandinavian ChemoTech är ett forsknings- och utvecklingsbolag som har tagit fram teknologin Tumörspecifik Elektroporation – TSEâ„¢ för behandling av olika cancerformer. Teknologin …See details»
Our Products - ChemoTech
The TSE technology is built on three patented products: the main TSE unit, IQwaveâ„¢, the handheld probe and the treatment electrodes. The IQwave system is a completely new …See details»